Michael R. Klapal

FDA investigator

Appears on 5 documents from 2013 to 2019, mostly at sites in New Jersey. Most often cites stability testing (21 CFR 211.166).

5
Documents on file
4.0
Observations per 483
2013
First seen
2019
Most recent

What they cite most

From 16 observations

Activity by year

2013: 2, 2015: 1, 2018: 1, 2019: 1

Where

New Jersey 3 · Germany 1 · Pennsylvania 1

Is Michael R. Klapal coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

5 documents, newest first
FirmOpen
483 KVK-Tech, IncApr 16, 2019 · Newtown, Pennsylvania
483 Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen)Feb 9, 2018 · Ravensburg, Germany
483 Pharmacy CreationsSep 30, 2015 · Randolph, New Jersey
Response Pharmacy Creations, LLCSep 3, 2013 · Randolph, New Jersey
483 Pharmacy CreationsAug 19, 2013 · Randolph, New Jersey

About this profile

What does Michael R. Klapal inspect?

Michael R. Klapal appears on 5 documents on file covering 3 sites, mostly in New Jersey.

What do they cite most often?

21 CFR 211.166 (stability testing), followed by 21 CFR 211.113(b) and 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Michael R. Klapal is dated Apr 16, 2019.